Daan van den Noort — Non Executive Chairman
Daan is an experienced investment director having previously been a general practitioner until 1988, when he joined the pharmaceutical industry as Marketing Manager of Pharmacia. In 1994 he joined Genentech Inc. as Managing Director The Netherlands. From 1999 he joined Ferring Geneesmiddelen as General Manager and in 2001 he joined a venture capital fund, Biotech Turnaround Fund (“BTF”). In 2010 Daan set up DvDNA Consult an advisory firm based in Amsterdam providing services in the field of finance, biotechnology, business development and management. Daan serves as an external advisor for KPMG Meijburg & Co and Mercurius Investments BV. He serves as director for Bioseutica Lugano, Pharmacell NL, Zenith International Reserves Limited, Zenith International Bond Funds Limited and Hume Global Investors PCC Limited.
Johannes van den Aker – Non Executive Chairman
Johannes van den Aker has held HR and IT management positions in multinational companies previously with Albany International (USA) and more recently with Wavin N.V. (The Netherlands). He is experienced in IT risk and compliance management and has managed organisational change and restructuring projects as well as HR and ERP systems implementations.
Sarah Bertolotti – Finance Director
Sarah Bertolotti is a chartered accountant who trained with Arthur Andersen. She is currently also director of Blavod Wines and Spirits plc and has previously held finance management positions with Hilton Hotels and Regus.